This company listing is no longer active
PHC Stock Overview
Provides agricultural biological products and technology solutions in the United Kingdom, the United States, Mexico, Spain, and Brazil. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 6/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Plant Health Care plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.089 |
52 Week High | UK£0.10 |
52 Week Low | UK£0.032 |
Beta | 0.81 |
1 Month Change | 1.42% |
3 Month Change | 40.00% |
1 Year Change | -4.03% |
3 Year Change | -31.87% |
5 Year Change | 13.33% |
Change since IPO | -84.20% |
Recent News & Updates
Recent updates
Plant Health Care plc's (LON:PHC) P/S Is Still On The Mark Following 76% Share Price Bounce
Jun 05One Analyst Just Shaved Their Plant Health Care plc (LON:PHC) Forecasts Dramatically
Nov 23Plant Health Care plc's (LON:PHC) Share Price Matching Investor Opinion
Sep 28Would Shareholders Who Purchased Plant Health Care's (LON:PHC) Stock Five Years Be Happy With The Share price Today?
Feb 10Shareholder Returns
PHC | GB Chemicals | GB Market | |
---|---|---|---|
7D | 0.3% | -3.7% | -0.9% |
1Y | -4.0% | -22.4% | 5.0% |
Return vs Industry: PHC exceeded the UK Chemicals industry which returned -26.2% over the past year.
Return vs Market: PHC underperformed the UK Market which returned 11.8% over the past year.
Price Volatility
PHC volatility | |
---|---|
PHC Average Weekly Movement | 15.6% |
Chemicals Industry Average Movement | 5.9% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 10.8% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: PHC's share price has been volatile over the past 3 months.
Volatility Over Time: PHC's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 55 | Jeff Tweedy | www.planthealthcare.com |
Plant Health Care plc, together with its subsidiaries, provides agricultural biological products and technology solutions in the United Kingdom, the United States, Mexico, Spain, and Brazil. It operates through Commercial – Americas; Commercial – Mexico; Commercial – Rest of World; and Plant Response Elicitor Technology (PREtec) segments. The company offers Harpin aß, a recombinant protein, which acts as a biostimulant to enhance the quality, nutrient use, tolerance to abiotic stress, and yield quality of crops; Saori, a vaccine for plants that promotes healthy growth of soybeans and helps them fight disease; and Obrana, a foliar product to help growers control a range of fungal and bacterial plant pathogens within fruits, nuts, vegetables, and row crops.
Plant Health Care plc Fundamentals Summary
PHC fundamental statistics | |
---|---|
Market cap | UK£30.48m |
Earnings (TTM) | -UK£3.07m |
Revenue (TTM) | UK£8.59m |
3.5x
P/S Ratio-9.9x
P/E RatioIs PHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PHC income statement (TTM) | |
---|---|
Revenue | US$11.21m |
Cost of Revenue | US$4.44m |
Gross Profit | US$6.77m |
Other Expenses | US$10.77m |
Earnings | -US$4.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.012 |
Gross Margin | 60.37% |
Net Profit Margin | -35.70% |
Debt/Equity Ratio | 4.7% |
How did PHC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/08/21 01:38 |
End of Day Share Price | 2024/08/21 00:00 |
Earnings | 2023/12/31 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Plant Health Care plc is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Andrew Simms | Arden Partners Plc. |
John-Marc Bunce | Cavendish |
John-Marc Bunce | Cavendish Historical (Cenkos Securities) |